This study is collecting blood samples and information from kidney transplant patients. The goal is to develop a new, non-invasive test that can detect donor-derived cell-free DNA (dd-cfDNA) in your blood. This DNA comes from your transplanted kidney and can help doctors check on the health of your new organ. You can join if you are 18 or older, have had a kidney transplant, and are having a biopsy because your doctor thinks it's needed. We are looking for 400 participants to help with this research. The main goal is to see if we can detect dd-cfDNA from your blood samples, measured 18 months after the samples are collected.

Study design

This is an observational study, meaning researchers will collect information and samples without giving any new treatments. It plans to enroll 400 participants.

What's involved

You would provide a whole blood sample and clinical information at the time of your indication biopsy, before the biopsy procedure. Leftover genetic samples from your kidney donor will also be collected.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, detection of donor-derived cell-free DNA, is measured at 18 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.